David M Kelly's Insider Trades & SAST Disclosures
David M Kelly's most recent trade in Kforce Inc. was a trade of 398 Common Stock done . Disclosure was reported to the exchange on March 7, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern David M Kelly.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Kforce Inc. | David M. Kelly | Chief Operating Officer | Other type of transaction at price $ 0.00 per share. | 07 Mar 2025 | 398 | 94,662 (0%) | 0% | 0 | Common Stock | |
| Kforce Inc. | David M. Kelly | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2024 | 21,270 | 94,264 (0%) | 0% | 0 | Common Stock | |
| Kforce Inc. | David M. Kelly | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 56.71 per share. | 27 Dec 2024 | 8,808 | 72,994 (0%) | 0% | 56.7 | 499,502 | Common Stock |
| Kforce Inc. | David M. Kelly | Chief Operating Officer | Other type of transaction at price $ 0.00 per share. | 06 Dec 2024 | 337 | 81,802 (0%) | 0% | 0 | Common Stock | |
| Kforce Inc. | David M. Kelly | Chief Operating Officer | Other type of transaction at price $ 0.00 per share. | 13 Sep 2024 | 321 | 81,465 (0%) | 0% | 0 | Common Stock | |
| Kforce Inc. | David M. Kelly | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 65.75 per share. | 02 Aug 2024 | 6,000 | 81,144 (0%) | 0% | 65.8 | 394,500 | Common Stock |
| Kforce Inc. | David M. Kelly | Chief Operating Officer | Other type of transaction at price $ 0.00 per share. | 14 Jun 2024 | 326 | 87,144 (0%) | 0% | 0 | Common Stock | |
| Kforce Inc. | David M. Kelly | Chief Operating Officer | Other type of transaction at price $ 0.00 per share. | 15 Mar 2024 | 288 | 86,818 (0%) | 0% | 0 | Common Stock | |
| Kforce Inc. | David Kelly M. | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2023 | 16,726 | 86,530 (0%) | 0% | 0 | Common Stock | |
| Kforce Inc. | David Kelly M. | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2023 | 2,877 | 69,804 (0%) | 0% | 0 | Common Stock | |
| Kforce Inc. | Kelly M. David | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 67.84 per share. | 27 Dec 2023 | 10,285 | 66,927 (0%) | 0% | 67.8 | 697,734 | Common Stock |
| Kforce Inc. | M. Kelly David | Chief Operating Officer | Other type of transaction at price $ 0.00 per share. | 15 Dec 2023 | 309 | 77,212 (0%) | 0% | 0 | Common Stock | |
| Kforce Inc. | M. Kelly David | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 70.00 per share. | 11 Dec 2023 | 3,194 | 76,903 (0%) | 0% | 70 | 223,580 | Common Stock |
| Kforce Inc. | Kelly M. David | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 70.00 per share. | 11 Dec 2023 | 1,806 | 80,097 (0%) | 0% | 70 | 126,420 | Common Stock |
| Kforce Inc. | David M. Kelly | EVP, Chief Financial Officer | Other type of transaction at price $ 0.00 per share. | 16 Jun 2023 | 338 | 81,547 (0%) | 0% | 0 | Common Stock | |
| Kforce Inc. | David M. Kelly | EVP, Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 56.59 per share. | 18 May 2023 | 5,987 | 81,209 (0%) | 0% | 56.6 | 338,804 | Common Stock |
| Kforce Inc. | David M. Kelly | EVP, Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 56.90 per share. | 15 May 2023 | 12,813 | 87,196 (0%) | 0% | 56.9 | 729,060 | Common Stock |
| Kforce Inc. | David M. Kelly | EVP, Chief Financial Officer | Other type of transaction at price $ 0.00 per share. | 10 Mar 2023 | 337 | 100,009 (0%) | 0% | 0 | Common Stock | |
| Kforce Inc. | David M. Kelly | EVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2022 | 16,414 | 99,672 (0%) | 0% | 0 | Common Stock | |
| Kforce Inc. | David M. Kelly | EVP, Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 54.97 per share. | 27 Dec 2022 | 14,321 | 83,258 (0%) | 0% | 55.0 | 787,225 | Common Stock |
| Kforce Inc. | David M. Kelly | EVP, Chief Financial Officer | Other type of transaction at price $ 0.00 per share. | 09 Dec 2022 | 438 | 97,579 (0%) | 0% | 0 | Common Stock | |
| Kforce Inc. | David M. Kelly | EVP, Chief Financial Officer | Other type of transaction at price $ 0.00 per share. | 16 Sep 2022 | 385 | 97,141 (0%) | 0% | 0 | Common Stock | |
| Kforce Inc. | David M. Kelly | EVP, Chief Financial Officer | Other type of transaction at price $ 0.00 per share. | 10 Jun 2022 | 349 | 96,756 (0%) | 0% | 0 | Common Stock | |
| Kforce Inc. | David M. Kelly | EVP, Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 75.44 per share. | 29 Mar 2022 | 5,000 | 96,407 (0%) | 0% | 75.4 | 377,200 | Common Stock |
| Kforce Inc. | David M. Kelly | EVP, Chief Financial Officer | Other type of transaction at price $ 0.00 per share. | 11 Mar 2022 | 337 | 101,407 (0%) | 0% | 0 | Common Stock | |
| Kforce Inc. | David M. Kelly | EVP, Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 70.00 per share. | 09 Mar 2022 | 417 | 101,070 (0%) | 0% | 70 | 29,190 | Common Stock |
| Kforce Inc. | David M. Kelly | EVP, Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 76.99 per share. | 27 Dec 2021 | 15,487 | 82,409 (0%) | 0% | 77.0 | 1,192,344 | Common Stock |
| Kforce Inc. | David M. Kelly | EVP, Chief Financial Officer | Other type of transaction at price $ 0.00 per share. | 10 Dec 2021 | 339 | 97,896 (0%) | 0% | 0 | Common Stock | |
| Mesa Laboratories, Inc. | David M. Kelly | Director | 08 Nov 2021 | 18 | 569 | - | - | Non Qualified Stock Option | ||
| Mesa Laboratories, Inc. | David M. Kelly | Director | Sale of securities on an exchange or to another person at price $ 324.06 per share. | 08 Nov 2021 | 18 | 2,600 (0%) | 0% | 324.1 | 5,833 | Common Stock |
| Mesa Laboratories, Inc. | David M. Kelly | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 58.50 per share. | 08 Nov 2021 | 18 | 2,618 (0%) | 0% | 58.5 | 1,053 | Common Stock |
| Kforce Inc. | David M. Kelly | EVP, Chief Financial Officer | Other type of transaction at price $ 0.00 per share. | 10 Sep 2021 | 413 | 97,557 (0%) | 0% | 0 | Common Stock | |
| Mesa Laboratories, Inc. | David M. Kelly | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Sep 2021 | 431 | 431 | - | - | Restricted Stock Units - 6 | |
| Mesa Laboratories, Inc. | David M. Kelly | Director | Sale of securities on an exchange or to another person at price $ 267.29 per share. | 31 Aug 2021 | 603 | 2,600 (0%) | 0% | 267.3 | 161,176 | Common Stock |
| Mesa Laboratories, Inc. | David M. Kelly | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2021 | 308 | 0 | - | - | Restricted Stock Units - 5 | |
| Mesa Laboratories, Inc. | David M. Kelly | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2021 | 308 | 3,203 (0%) | 0% | 0 | Common Stock | |
| Kforce Inc. | David M. Kelly | EVP, Chief Financial Officer | Other type of transaction at price $ 0.00 per share. | 11 Jun 2021 | 348 | 97,144 (0%) | 0% | 0 | Common Stock | |
| Mesa Laboratories, Inc. | David M. Kelly | Director | Sale of securities on an exchange or to another person at price $ 260.28 per share. | 04 Jun 2021 | 851 | 2,600 (0%) | 0% | 260.3 | 221,498 | Common Stock |
| Mesa Laboratories, Inc. | David M. Kelly | Director | 04 Jun 2021 | 200 | 677 | - | - | Non Qualified Stock Option | ||
| Mesa Laboratories, Inc. | David M. Kelly | Director | 04 Jun 2021 | 200 | 877 | - | - | Non Qualified Stock Option | ||
| Mesa Laboratories, Inc. | David M. Kelly | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 122.66 per share. | 04 Jun 2021 | 200 | 3,361 (0%) | 0% | 122.7 | 24,532 | Common Stock |
| Mesa Laboratories, Inc. | David M. Kelly | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 97.78 per share. | 04 Jun 2021 | 200 | 3,161 (0%) | 0% | 97.8 | 19,556 | Common Stock |
| Mesa Laboratories, Inc. | David M. Kelly | Director | 04 Jun 2021 | 189 | 1,077 | - | - | Non Qualified Stock Option | ||
| Mesa Laboratories, Inc. | David M. Kelly | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 70.56 per share. | 04 Jun 2021 | 189 | 2,961 (0%) | 0% | 70.6 | 13,336 | Common Stock |
| Mesa Laboratories, Inc. | David M. Kelly | Director | 04 Jun 2021 | 172 | 1,266 | - | - | Non Qualified Stock Option | ||
| Mesa Laboratories, Inc. | David M. Kelly | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 89.70 per share. | 04 Jun 2021 | 172 | 2,772 (0%) | 0% | 89.7 | 15,428 | Common Stock |
| Mesa Laboratories, Inc. | David M. Kelly | Director | 04 Jun 2021 | 90 | 587 | - | - | Non Qualified Stock Option | ||
| Mesa Laboratories, Inc. | David M. Kelly | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 142.40 per share. | 04 Jun 2021 | 90 | 3,451 (0%) | 0% | 142.4 | 12,816 | Common Stock |
| Kforce Inc. | David M. Kelly | EVP, Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 60.72 per share. | 17 May 2021 | 21,500 | 96,796 (0%) | 0% | 60.7 | 1,305,480 | Common Stock |
| Kforce Inc. | David M. Kelly | EVP, Chief Financial Officer | Other type of transaction at price $ 0.00 per share. | 12 Mar 2021 | 400 | 118,296 (0%) | 0% | 0 | Common Stock | |
| Kforce Inc. | David M. Kelly | EVP, Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 47.47 per share. | 11 Feb 2021 | 15,000 | 117,896 (0%) | 0% | 47.5 | 712,050 | Common Stock |
| Kforce Inc. | David M. Kelly | EVP, Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 42.54 per share. | 27 Dec 2020 | 14,915 | 100,941 (0%) | 0% | 42.5 | 634,484 | Common Stock |
| Mesa Laboratories, Inc. | David M. Kelly | Director | Sale of securities on an exchange or to another person at price $ 283.18 per share. | 11 Dec 2020 | 250 | 2,350 (0%) | 0% | 283.2 | 70,795 | Common Stock |
| Kforce Inc. | David M. Kelly | EVP, Chief Financial Officer | Other type of transaction at price $ 0.00 per share. | 04 Dec 2020 | 466 | 115,856 (0%) | 0% | 0 | Common Stock | |
| Mesa Laboratories, Inc. | David M. Kelly | Director | Sale of securities on an exchange or to another person at price $ 283.31 per share. | 16 Nov 2020 | 704 | 2,600 (0%) | 0% | 283.3 | 199,450 | Common Stock |
| Mesa Laboratories, Inc. | David M. Kelly | Director | 16 Nov 2020 | 17 | 1,438 | - | - | Non Qualified Stock Option | ||
| Mesa Laboratories, Inc. | David M. Kelly | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 58.53 per share. | 16 Nov 2020 | 17 | 3,304 (0%) | 0% | 58.5 | 995 | Common Stock |
| Mesa Laboratories, Inc. | David M. Kelly | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Nov 2020 | 477 | 0 | - | - | Restricted Stock Units - 3 | |
| Mesa Laboratories, Inc. | David M. Kelly | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Nov 2020 | 477 | 3,287 (0%) | 0% | 0 | Common Stock | |
| Mesa Laboratories, Inc. | David M. Kelly | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Nov 2020 | 308 | 308 | - | - | Restricted Stock Units - 5 | |
| Kforce Inc. | David M. Kelly | EVP, Chief Financial Officer | Other type of transaction at price $ 0.00 per share. | 11 Sep 2020 | 589 | 115,390 (0%) | 0% | 0 | Common Stock | |
| Mesa Laboratories, Inc. | David M. Kelly | Director | 28 Aug 2020 | 600 | 1,455 | - | - | Non Qualified Stock Option | ||
| Mesa Laboratories, Inc. | David M. Kelly | Director | Sale of securities on an exchange or to another person at price $ 245.00 per share. | 28 Aug 2020 | 600 | 2,810 (0%) | 0% | 245 | 147,000 | Common Stock |
| Mesa Laboratories, Inc. | David M. Kelly | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 122.66 per share. | 28 Aug 2020 | 600 | 3,410 (0%) | 0% | 122.7 | 73,596 | Common Stock |
| Mesa Laboratories, Inc. | David M. Kelly | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 142.40 per share. | 28 Aug 2020 | 180 | 2,990 (0%) | 0% | 142.4 | 25,632 | Common Stock |
| Mesa Laboratories, Inc. | David M. Kelly | Director | 28 Aug 2020 | 180 | 2,055 | - | - | Non Qualified Stock Option | ||
| Mesa Laboratories, Inc. | David M. Kelly | Director | Sale of securities on an exchange or to another person at price $ 244.00 per share. | 28 Aug 2020 | 180 | 2,810 (0%) | 0% | 244 | 43,920 | Common Stock |
| Mesa Laboratories, Inc. | David M. Kelly | Director | Sale of securities on an exchange or to another person at price $ 247.72 per share. | 17 Aug 2020 | 800 | 2,810 (0%) | 0% | 247.7 | 198,176 | Common Stock |
| Mesa Laboratories, Inc. | David M. Kelly | Director | 17 Aug 2020 | 800 | 2,235 | - | - | Non Qualified Stock Option | ||
| Mesa Laboratories, Inc. | David M. Kelly | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 97.78 per share. | 17 Aug 2020 | 800 | 3,610 (0%) | 0% | 97.8 | 78,224 | Common Stock |
| Kforce Inc. | David M. Kelly | EVP, Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 37.00 per share. | 13 Aug 2020 | 12,100 | 114,801 (0%) | 0% | 37 | 447,700 | Common Stock |
| Kforce Inc. | David M. Kelly | EVP, Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 38.06 per share. | 13 Aug 2020 | 400 | 126,901 (0%) | 0% | 38.1 | 15,224 | Common Stock |
| Mesa Laboratories, Inc. | David M. Kelly | Director | Sale of securities on an exchange or to another person at price $ 250.00 per share. | 10 Aug 2020 | 942 | 2,810 (0%) | 0% | 250 | 235,500 | Common Stock |
| Mesa Laboratories, Inc. | David M. Kelly | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 70.56 per share. | 10 Aug 2020 | 942 | 3,752 (0%) | 0% | 70.6 | 66,468 | Common Stock |
| Mesa Laboratories, Inc. | David M. Kelly | Director | 10 Aug 2020 | 942 | 3,035 | - | - | Non Qualified Stock Option | ||
| Mesa Laboratories, Inc. | David M. Kelly | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 89.70 per share. | 10 Aug 2020 | 344 | 3,154 (0%) | 0% | 89.7 | 30,857 | Common Stock |
| Mesa Laboratories, Inc. | David M. Kelly | Director | Sale of securities on an exchange or to another person at price $ 250.00 per share. | 10 Aug 2020 | 344 | 2,810 (0%) | 0% | 250 | 86,000 | Common Stock |
| Mesa Laboratories, Inc. | David M. Kelly | Director | 10 Aug 2020 | 344 | 4,062 | - | - | Non Qualified Stock Option | ||
| Mesa Laboratories, Inc. | David M. Kelly | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 58.51 per share. | 10 Aug 2020 | 85 | 2,895 (0%) | 0% | 58.5 | 4,973 | Common Stock |
| Mesa Laboratories, Inc. | David M. Kelly | Director | Sale of securities on an exchange or to another person at price $ 250.00 per share. | 10 Aug 2020 | 85 | 2,810 (0%) | 0% | 250 | 21,250 | Common Stock |
| Mesa Laboratories, Inc. | David M. Kelly | Director | 10 Aug 2020 | 85 | 3,977 | - | - | Non Qualified Stock Option | ||
| Mesa Laboratories, Inc. | David M. Kelly | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2020 | 265 | 265 | - | - | Restricted Stock Units - 4 | |
| Mesa Laboratories, Inc. | David M. Kelly | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2020 | 30 | 2,810 (0%) | 0% | 0 | Common Stock | |
| Mesa Laboratories, Inc. | David M. Kelly | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2020 | 30 | 90 | - | - | Restricted Stock Units - 1 | |
| Kforce Inc. | David M. Kelly | EVP, Chief Financial Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 05 Jun 2020 | 2,500 | 127,301 (0%) | 0% | 0 | Common Stock | |
| Kforce Inc. | David M. Kelly | EVP, Chief Financial Officer | Other type of transaction at price $ 0.00 per share. | 05 Jun 2020 | 606 | 129,801 (0%) | 0% | 0 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges